The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
9-Oxo-9-(4-(4-(trifluoromethyl)phenyl)piperazin-1-yl)nonanoic acid ID: ALA4793848
PubChem CID: 71523643
Max Phase: Preclinical
Molecular Formula: C20H27F3N2O3
Molecular Weight: 400.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCCCCCCC(=O)N1CCN(c2ccc(C(F)(F)F)cc2)CC1
Standard InChI: InChI=1S/C20H27F3N2O3/c21-20(22,23)16-8-10-17(11-9-16)24-12-14-25(15-13-24)18(26)6-4-2-1-3-5-7-19(27)28/h8-11H,1-7,12-15H2,(H,27,28)
Standard InChI Key: IRQWPZTVZZRGMK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
24.5735 -3.0005 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.5776 -2.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8637 -2.5883 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.8629 -2.1833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2674 -2.8932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0805 -2.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4952 -2.1901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0866 -1.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2674 -1.4760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0446 -2.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6330 -1.4712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8125 -1.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4025 -2.1823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8149 -2.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6341 -2.8943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1681 -1.4711 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.3124 -2.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7178 -2.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7242 -1.4880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5349 -2.9071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9403 -3.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7575 -3.6204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1629 -4.3300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9800 -4.3337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3854 -5.0432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2026 -5.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6080 -5.7565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.6144 -4.3411 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 9 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 10 1 0
13 2 1 0
2 16 1 0
7 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 400.44Molecular Weight (Monoisotopic): 400.1974AlogP: 4.17#Rotatable Bonds: 9Polar Surface Area: 60.85Molecular Species: ACIDHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.57CX Basic pKa: 2.85CX LogP: 3.95CX LogD: 1.32Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.63Np Likeness Score: -0.98
References 1. Devine R,Kelada M,Leonard S,Martin DSD,Walsh JMD,Breen CJ,Driver RB,Kinsella GK,Findlay JBC,Stephens JC. (2020) Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase., 202 [PMID:32645646 ] [10.1016/j.ejmech.2020.112416 ]